BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 16061678)

  • 1. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line.
    Li Y; Ellis KL; Ali S; El-Rayes BF; Nedeljkovic-Kurepa A; Kucuk O; Philip PA; Sarkar FH
    Pancreas; 2004 May; 28(4):e90-5. PubMed ID: 15097869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
    Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.
    Ban JO; Lee HS; Jeong HS; Song S; Hwang BY; Moon DC; Yoon DY; Han SB; Hong JT
    Mol Cancer Res; 2009 Jun; 7(6):870-9. PubMed ID: 19531569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S; Zhang Y; Ali S; Bhuiyan M; Wang Z; Chiao PJ; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2005 Oct; 65(19):9064-72. PubMed ID: 16204081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
    Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
    Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
    Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
    Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
    Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
    Banerjee S; Zhang Y; Wang Z; Che M; Chiao PJ; Abbruzzese JL; Sarkar FH
    Int J Cancer; 2007 Feb; 120(4):906-17. PubMed ID: 17131310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
    Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
    Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
    Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
    J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
    Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
    Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
    Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
    Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein inhibits NF-kappa B activation in prostate cancer cells.
    Davis JN; Kucuk O; Sarkar FH
    Nutr Cancer; 1999; 35(2):167-74. PubMed ID: 10693171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
    Burich RA; Holland WS; Vinall RL; Tepper C; White RW; Mack PC
    BJU Int; 2008 Nov; 102(10):1458-66. PubMed ID: 18565171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
    Li Y; Xing D; Chen Q; Chen WR
    Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.